Viral kinetics in genotype 1 chronic hepatitis C patients during therapy with 2 different doses of peginterferon alfa-2b plus ribavirin
Author:
Funder
Schering-Plough
Publisher
Wiley
Subject
Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1053/jhep.2002.32150/fullpdf
Reference22 articles.
1. Pegylated interferon-α-2b: pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy data;Glue;Clin Pharmacol Ther,2000
2. Phase I study of polyethylene glycol (PEG) interferon alpha-2b (Intron A) in CML patients [Abstract];Talpaz;Blood,1998
3. A dose-ranging study of pegylated interferon alfa-2b and ribavirin in chronic hepatitis C;Glue;Hepatology,2000
4. A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C;Lindsay;Hepatology,2001
5. Peginterferon alfa-2a in patients with chronic hepatitis C;Zeuzem;N Engl J Med,2000
Cited by 104 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Ribavirin;Meyler's Side Effects of Drugs;2016
2. Impact of the peginterferon-α 2a and ribavirin plasma levels on viral kinetics and sustained virological response in genotype 1 HCV/HIV-co-infected patients with the unfavourable non-CC IL28B genotypes;Journal of Viral Hepatitis;2013-07-17
3. Outcome of Double-Filtration Plasmapheresis plus Interferon Treatment in Nonresponders to Pegylated Interferon plus Ribavirin Combination Therapy;Digestive Diseases;2013
4. Significance of a reduction in HCV RNA levels at 4 and 12 weeks in patients infected with HCV genotype 1b for the prediction of the outcome of combination therapy with peginterferon and ribavirin;BMC Infectious Diseases;2012-11-27
5. Baseline factors and early viral response (week 4) to antiviral therapy with peginterferon and ribavirin for predicting sustained virologic response in patients infected with hepatitis C virus genotype 1: A multicenter study;Journal of Medical Virology;2012-11-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3